-
Verteporfin (trade name Visudyne), a
benzoporphyrin derivative, is a
medication used as a
photosensitizer for
photodynamic therapy to
eliminate the abnormal...
-
Julia Levy and
colleagues developed a
novel photosensitizer,
verteporfin.
Verteporfin, a
porphyrin derivative, is
activated at 690 nm, a much longer...
- areas. This
technique has been
applied in
macular degeneration using verteporfin. PDT is
considered a
noninvasive cancer treatment,
involving the interaction...
- be
evaluated with caution. Full-dose
photodynamic therapy (PDT) with
verteporfin was
first described in CSR in 2003. Later, reduced-settings PDT (half-dose...
-
therapy with
verteporfin. It was
concluded from the two year,
phase III
study that
ranibizumab was
superior to
photodynamic therapy with
verteporfin in the...
- retina). She is
credited for
developing photodynamic therapy (PDT) with
verteporfin (Visudyne), the
first pharmacologic therapy for
retinal disease. She...
-
Padeliporfin Porphyrin derivatives (Porfimer
sodium Talaporfin Temoporfin Verteporfin)
Other #WHO-EM ‡Withdrawn from
market Clinical trials: †Phase III §Never...
-
Padeliporfin Porphyrin derivatives (Porfimer
sodium Talaporfin Temoporfin Verteporfin)
Other #WHO-EM ‡Withdrawn from
market Clinical trials: †Phase III §Never...
- lutetium,
Palladium bacteriopheophorbide, Purlytin, and Talaporfin.
Verteporfin is
approved to
treat eye
conditions such as
macular degeneration, myopia...
-
Photodynamic therapy has also been used to
treat wet AMD. The drug
verteporfin is
administered intravenously;
light of a
certain wavelength is then...
